Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Using 5G technology for follow-up care of heart devices

Official title: Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices: a Prospective, Paired, Self-controlled, Non-inferiority, Multicenter Clinical Trial

Run by The Third People's Hospital of Chengdu · NCT06652750 · Data updated 2026-11-12

This study is testing if using 5G technology for remote check-ups can be as safe and effective as regular in-person visits for people with heart devices like pacemakers and defibrillators.

More Sick Sinus Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment688 (estimated)
SponsorThe Third People's Hospital of Chengdu
Academic / other
Locations2 sites (Guangzhou, Guangdong and 1 other locations)
StatusRecruiting
StartedNovember 13, 2024
Main results expectedFebruary 1, 2025
Study endsFebruary 1, 2026
Registry record updatedNovember 21, 2024
Trial IDNCT06652750 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have recently received a cardiovascular implantable electronic device and have not yet undergone their first follow-up.

Probably not a fit

Patients with a life expectancy of less than one year or those unable to cooperate with treatment or follow-up will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical study evaluates the safety and effectiveness of 5G cloud follow-up for patients with cardiovascular implantable electronic devices (CIED) such as pacemakers and defibrillators. It employs a prospective, paired, self-controlled, non-inferiority design across multiple centers to compare traditional in-office follow-ups with remote monitoring via 5G technology. Participants will receive both types of follow-up during their regular clinic visits to assess the feasibility and outcomes of remote programming. The study aims to enhance patient monitoring and timely intervention while reducing the need for hospital visits.

Why it matters

Potential benefit: If successful, this approach could significantly improve the management and monitoring of patients with heart devices, leading to better health outcomes.

How similar studies have gone: While remote monitoring has been explored in other studies, the specific application of 5G cloud follow-up for CIEDs is a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years, gender unspecified;
2. Patients who have not undergone their first clinic follow-up after the implantation of cardiovascular implantable electronic devices (CIED); Note: In this study, CIED includes pacemakers, implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy pacemakers (CRT-P) and defibrillators (CRT-D), excluding implantable cardiac event recorders (ICM) and implantable cardiovascular monitors.
3. Willing to participate in this clinical study and have signed the informed consent form in writing.

Exclusion Criteria:

* Exclusion Criteria:

If meeting any of the following, the individual cannot be included:

1. Life expectancy \< 1 year.
2. Inability to cooperate with treatment or follow-up, such as having mental illness.
3. Participated in other clinical studies within 30 days before enrollment. Other situations that the researcher deems unsuitable for inclusion.

Where it's running

  • Sun Yat-sen Memorial Hospital
    Guangzhou, Guangdong, China
    Recruiting
  • The Third People's Hospital of Chengdu
    Chengdu, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.